Rare diseases
Investigational molecules
Locations
Back to Germany1 819 clinical trials in Potsdam, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
GermanyStudy of chlorhexidine, metronidazole, and FB301 for the treatment of women with bacterial vaginosis
GermanyA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
GermanyStudy of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy
GermanyA study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.
GermanyStudy of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome
GermanyA study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.
GermanyStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
GermanyN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
GermanyEvaluation of Safety, Pharmacokinetics, and Efficacy of RO7782493 and Panitumumab in Advanced Solid Tumors with KRAS G12D Mutation
GermanyStudy of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment
GermanyA Study of Cemiplimab Given Before Surgery in Patients with Early Stage Merkel Cell Carcinoma of the Skin
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies for triple-negative, HER2-positive, and hormone receptor-positive variants. Research encompasses new combination therapies and targeted treatments.
Multiple studies are evaluating novel drug combinations and personalized therapeutic approaches.
Clinical research targeting various skin conditions, including atopic dermatitis and chronic skin disorders. Studies focus on both topical and systemic treatments.
Investigations include both traditional and innovative therapeutic approaches for skin conditions.
Studies focusing on multiple sclerosis treatment options, evaluating new medications and comparing their effectiveness to existing therapies.
Research aims to improve treatment outcomes and quality of life for patients with neurological conditions.
Research focusing on cardiovascular disease management and innovative treatments for related conditions, including studies on lipid management.
Trials aim to reduce major cardiovascular events and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
